Immunohistochemical analysis of immune response in breast cancer and melanoma patients after laser immunotherapy

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 7900, Issue , 2011, Pages

  Nordquist, Robert E ^a,b   Bishop, Shelly L ^a,b   Ferguson, Halie ^c   Vaughan, Melville B ^c   Jose, Jessnie ^c   Kastl, Katherine ^c   Nguyen, Long ^c   Li, Xiaosong ^c,d,e   Liu, Hong ^f   Chen, Wei R ^c  

^a ImmunoPhotonics Inc   (United States)

^b Wound Healing of Oklahoma   (United States)

^c UNIVERSITY OF CENTRAL OKLAHOMA   (United States)

^d First Affiliated Hospital of Chinese   (China)

^e CHINESE PLA GENERAL HOSPITAL   (China)

^f USA   (United States)

Author keywords

Anti tumor immune response; Clusters of differentiations (CDs); Glycated chitosan; Imiquimod; Immunohistochemical analysis; Laser immunotherapy; Melanoma; Metastatic breast cancer

Indexed keywords

ANTI-TUMOR IMMUNE; CLUSTERS OF DIFFERENTIATIONS (CDS); GLYCATED CHITOSAN; IMIQUIMOD; IMMUNOHISTOCHEMICAL ANALYSIS; MELANOMA; METASTATIC BREAST CANCER;

CHITIN; CHITOSAN; DERMATOLOGY; DISEASES; IMMUNOLOGY; INFRARED DEVICES; ONCOLOGY; PATIENT TREATMENT; TUMORS;

INFRARED LASERS;

EID: 79953816799     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.874875     Document Type: Conference Paper

References (34)

1. Richman, S., Gutterman, J., Hersh, E., "Cancer Immunotherapy, " Canadian Medical Association Journal. 120, 322-324 (1979).
2. Baxevanis, C., Perez, S., Papamichail, M., "Cancer Immunotherapy, " Critical Reviews in Clinical Laboratory Sciences. 46 (4), 167-189 (2009).
3. Blattman, J., Greenberg, P., "Cancer immunotherapy: a treatment for the masses, " Science. 305 (5681), 200-205 (2004). (Pubitemid 38886725)
4. Rosenberg, S., "Cancer Immunotherapy: Challenges and Opportunities, Cancer Immunotherapy Progress in human tumour immunology and immunotherapy, " Nature. 411 (6835), 380-384 (2001).
5. Hwu, P., "Treating cancer by targeting the immune system, " The New England Journal Of Medicine. 363 (8), 779-781 (2010).
6. Rosenburg, S., Dudley, M., Restifo, N., Prestwich, R., Vile, R., et al., "Cancer Immunotherapy" New England Journal of Medicine. 359, 1072-1073 (2008).
7. Alexandrescu, D., Ichim, T., Riordan, N., Marincola, F., Di Nardo, A., et al., "Immunotherapy for melanoma: current status and perspectives." Journal Of Immunotherapy. 33 (6), 570-590 (2010).
8. Westwood, J., Berry, L., Wang, L., Duong, C., Pegram., et al., "Enhancing adoptive immunotherapy of cancer, " Expert Opinion On Biological Therapy. 10 (4), 531-545 (2010).
9. Waldman, T., "Immunotherapy: Past, Present, and Future, " Nature Medicine. 9, 269-277 (2003).
10. Chen, W., Adams, R., Carubelli, R., Nordquist, R., "Laser- photosensitizer assisted immunotherapy: A novel modality in cancer treatment, " Cancer Letters. 115, 25-30 (1997). (Pubitemid 27139852)
11. Chen, W., Zhu, W., Dynlacht, J., Liu, H., Nordquist, R., "Long-term tumor resistance induced by laser photo-immunotherapy, " International Journal of Cancer. 81, 808-812 (1999). (Pubitemid 29214394)
12. Chen, W., Singhal, A., Liu, H., Nordquist, R., "Laser immunotherapy induced antitumor immunity and its adoptive transfer, " Cancer Research. 61, 459-461 (2001). (Pubitemid 32128597)
13. Chen, W., Ritchey, J., Bartels, K., Liu, H., Nordquist, R., "Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats, " Cancer Research. 62, 4295-4299 (2002). (Pubitemid 34827285)
14. Chen, W., Carubelli, R., Liu, H., Nordquist, R., "Laser Immunotherapy: A Novel Treatment Modality for Metastatic Tumors, " Molecular Biotechnology. 25, 37-43 (2003). (Pubitemid 37100236)
15. Chen, W., Jeong, SW., Lucroy, M., Wolf, R., Howard, E., et al., "Induced anti-tumor immunity against DMBA-4 metastatic mammary tumors in rats using a novel approach, " International Journal of Cancer. 107 (6), 1053-1057 (2003). (Pubitemid 37429850)
16. Naylor, M., Chen, W., Teague, T.K., Perry, L., Nordquist, R., "In Situ Photo Immunotherapy: A Tumor-Directed Treatment Modality for Melanoma, " British Journal of Dermatology. 155, 1287-1292 (2006). (Pubitemid 44730010)
17. Li, X., Naylor, M., Nordquist, R., Teague, T.K., Howard, C.A., et al., "In Situ Photoimmunotherapy for Late-stage Melanoma Patients: a Preliminary Study, " Cancer Biology and Therapy. 10 (11), 1077-1214 (2010).
18. Li, X., Hode, T., Guerra, M., Ferrel, G., Lunn, J., et al., "Combined effects of selective photothermal therapy and immunoadjuvant against Stage IV breast cancer, " Journal of Innovative Optical Health Science. 3, 279-284 (2010).
19. Li, X., Ferrel, G., Guerra, M., Hode, T., Lunn, J., et al., "Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients, " Photochemical and Photobiological Sciences. In press (2011).
20. Baldridge, JR., McGowan, P., Evans, JT., Cluff, C., Mossman, S., et al., "Taking a toll on human disease: toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents" Expert Opin. Biol. Ther. 4, 1129-1138 (2004). (Pubitemid 38937554)
21. Hesling, C., D'lncan, M., Mansard, S., Franck, F., Corbin-Duval, A., et al., "In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases, " Br. J. Dermatol. 150, 761-767 (2004). (Pubitemid 38586231)
22. Steinmann, A., Funk, JO., Schuler, G., von den Driesch, P., "Topical imiquimod treatment of a cutaneous melanoma metastasis, " J. Am. Acad. Dermatol. 43, 555-556 (2000). (Pubitemid 30666755)
23. Bong, AB., Bonnekoh, B., Franke, L., Schön, MP., Ulrich, J., et al. "A topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma, " Dermatology. 205, 135-138 (2002).
24. Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., et al., "Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway, " Nat. Immunol. 3, 196-200 (2002). (Pubitemid 34141451)
25. Bilu, D., Sauder, D.N., "Imiquimod: modes of action, " Br. J Dermatol. 149 (Suppl 66), 5-8 (2003). (Pubitemid 38064505)
26. Gerster, J.F., Owens, M.L., Slade, H.B., Slade, H.B., Tomai, M.A., "Imiquimod applied topically: a novel immune response modifier and new class of drug, " Int. J. Immunopharmacol. 21, 1-14 (1999). (Pubitemid 29097684)
27. Chen, W., Carubelli, R., Liu, H., Nordquist., "Laser Immunotherapy: A Novel Treatment Modality for Metastatic Tumors, " Molecular Biotechnology. 25, 37-43 (2003). (Pubitemid 37100236)
28. Song, S., Zhou, F., Nordquist, R., Carubelli, R., Liu, H., et al., "Glycated chitosan as a new non-toxic immunological stimulant, " Immunopharmacology and Immunotoxicology. 31 (2), 202-208 (2009).
29. Zola, H., Swart, B., Banham, A., Barry, S., Beare, A., et al., "CD molecules 2006-human cell differentiation, " J. Immunol. Methods. 318, 1-2 (2007).
30. Mosser, D.D., Duchaine, J., Martin, L.H., "Biochemical and developmental characterization of the murine cluster of differentiation 1 antigen, " Immunology. 73 (3), 298-303 (1991).
31. Saalmüller, A., Pauly, T., Lunney, J.K., Boyd, P., Aasted, B., et al., "Overview of the Second International Workship to define swine cluster of differentiation (CD) antigens, " Veterinary immunology and immunopathology. 60 (3-4), 207-228 (1998). (Pubitemid 28201880)
32. Liu, J., Li, C., Ke, S., Satyanarayanajois, S., "Structure-based rational design of beta-hairpin peptides from discontinuous epitopes of cluster of differentiation 2 (CD2) protein to modulate cell adhesion interaction, " Journal of medicinal chemistry. 50 (17), 4038-4047 (2007). (Pubitemid 47301736)
33. Pitcher, C., Höning, S., Fingerhut, A., Bowers, K., Marsh, M., "Cluster of differentiation antigen 4 (CD4) endocytosis and adaptor complex binding require activation of the CD4 endocytosis signal by serine phosphorylation, " Molecular biology of the cell. 10 (3), 677-691 (1999). (Pubitemid 29144631)
34. Abdo, M., Irving, B., Hudson, P., Zola, H., "Development of a cluster of differentiation antibody-based protein microarray, " Journal of immunological methods. 305 (1), 3-9 (2005). (Pubitemid 41416716)